CONSOLIDATED STATEMENTS OF OPERATIONS (USD $)	3 Months Ended				6 Months Ended				86 Months Ended
	Jun. 30, 2014		Jun. 30, 2013		Jun. 30, 2014		Jun. 30, 2013		Jun. 30, 2014
Revenue	$ 0		$ 0		$ 0		$ 0		$ 0
Operating expense
Research and development	517,040	[1]	156,036	[1]	624,681	[1]	557,135	[1]	6,469,166	[1]
General & administrative	754,548	[2]	240,543	[2]	1,135,400	[2]	480,354	[2]	9,829,509	[2]
Total operating expense	1,274,801		428,646		1,785,012		1,084,556		17,502,932
Net operating loss	(1,274,801)		(428,646)		(1,785,012)		(1,084,556)		(17,502,932)
Other income (expense)
Interest income	6,066		1,531		11,639		1,655		92,766
Other income	0		0		0		0		244,479
Other expense	(42)		(129)		(281)		(345)		(5,264)
Total Other Income (Expense)	6,024		1,402		11,358		1,310		331,981
Net Loss	(1,268,777)		(427,244)		(1,773,654)		(1,083,246)		(17,170,951)
Loss per share
Net loss per share, basic and diluted	$ (0.01)		$ (0.01)		$ (0.02)		$ (0.02)		$ (0.33)
Basic and diluted weighted average number of common shares outstanding	89,237,872		66,606,105		89,237,872		64,412,577		52,592,648
Related Party
Operating expense
Research and development	$ 3,213	[3]	$ 32,067	[3]	$ 24,931	[3]	$ 47,067	[3]	$ 1,204,257	[3]

[1] Research and development expense includes stock option expenses of $20,410 and $8,220 for the quarters ending 6/30/2014 and 6/30/2013, respectively; $27,032 and $19,633 for the six month periods ending 6/30/2014 and 6/30/2013, respectively; and $482,912 for the period from inception through 6/30/2014

[2] General & administrative expense includes stock for services, stock option and warrant expenses of $102,383 and $5,318 for the quarters ending 6/30/2014 and 6/30/2013, respectively; $182,039 and $9,923 for the six month periods ending 6/30/2014 and 6/30/2013, respectively; and $3,444,392 for the period from inception through 6/30/2014 for stock options and warrants and $318,500 in stock for services.

[3] Includes $690,000 technology impairment charge for the period from inception through 6/30/2014